Skip to content
Parakho

Trident Lifeline Ltd

BSE 543616tridentlifeline.com

Q1 FY27, unaudited

Revenue
₹26.84 Cr
Profit after tax
₹5.02 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with BSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year ago6M FY26
Revenue from operations26.84+42.64%55.64
Other income0.53−1.57%2.53
Total income27.37+41.41%58.17
Employee benefit expense0.97+11.58%2.01
Finance costs0.49+50.86%0.92
Depreciation & amortisation0.70+36.37%0.75
Total expenses20.81+41.31%44.29
Profit before tax6.56+41.76%13.87
Tax expense1.54+33.91%4.20
Profit after tax5.02+44.36%9.68
Total comprehensive income———
Earnings per share
Earnings per share, basic₹4.26₹8.29
Earnings per share, diluted₹4.26₹8.29

Q1 FY27 — unaudited, from the company’s filing with BSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with BSE. Source

6M FY26 — from the company’s filing with BSE. Source

Q1 FY27 results for every company Parakho holds

Earnings call

Trident Lifeline Ltd has not filed a concall transcript in the last 4 quarters.

Filings

12 shown · 72 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Healthcare › Pharmaceuticals

Classification as published by BSE.

Companies also in Pharmaceuticals, in alphabetical order

All 196 companies in Pharmaceuticals

Page generated from filings held to 09 Oct 2026.